US HealthConnect Inc. (USH) Acquires AXIS Medical Education, a Jointly Accredited Provider with Extensive Oncology Experience and Renowned Leadership in Shared Decision-Making Education

AXIS Medical Education becomes newest member of USH’s Continuing Medical Education (CME) companies

Fort Washington, PA | December 1, 2021

US HealthConnect Inc. (USH) announced today the acquisition of AXIS Medical Education (AXIS), a Jointly Accredited Provider of education for global healthcare professionals, specializing in oncology and shared decision-making education design.

“USH has enjoyed nearly a decade of collaborations with AXIS leadership and team members,” said Frank C. Russomano, President & CEO of US HealthConnect, Inc. “AXIS is the industry leader in oncology education based on rigorous scientific evidence, and their expertise will benefit all stakeholders.”

“AXIS is the industry leader in oncology education based on rigorous scientific evidence, and their expertise will benefit all stakeholders.”

Frank C. Russomano
President & CEO, US HealthConnect

AXIS specializes in certified education that engages the interprofessional healthcare team and shared decision making (SDM), which includes taking into consideration patient values and preferences as a cornerstone for treatment decisions.

“We have championed SDM for years, using outcomes data to demonstrate its value,” said Linda Gracie-King, MHS, Managing Partner & Co-Founder of AXIS Medical Education. “We founded the Oncology Shared Decision-Making Resource Center^™ and the Oncology Shared Decision-Making Resource Collaborative (OSDMRC) to encourage patients and clinicians to co-create tools and resources that improve patient-provider relationships. We are thrilled to join USH and share their innovative mindset in global education.”

Marc Viens, MS, CMM, Managing Partner & Co-founder of AXIS, added, “Our mutual companies share the same core values—and we both produce award-winning education, loyal team members, and grantors who value our education designs. Joining USH is a natural fit, and we are excited for the future of oncology education and our combined contribution to improved patient outcomes.”

ABOUT US HEALTHCONNECT INC.

US HealthConnect, Inc., is a global organization whose subsidiaries are dedicated to improving the lives of patients and healthcare professionals through evidence-based education for clinicians. USH companies develop, produce, distribute, and measure the impact of education designed to improve the practice of medicine. USH subsidiaries include ReachMD®, a 12-time recipient of Medical Marketing & Media (MM&M) awards (including back-to-back Gold Winner in 2020 and 2021); Global Learning Collaborative® (GLC), a Jointly Accredited Provider; AXIS Medical Education, a jointly accredited provider; CME Companies Omnia Education®, Prova Education®, Medtelligence™, MedEd OnTheGo®, TotalCME®, and the Academy for Global Interprofessional Learning & Education (AGILE); Kynectiv®, a branched-learning and decision-making digital education platform; and Winding River Productions®, a full-service creative studio. More information is available at www.ushealthconnect.com.